Fluvoxamine CR in the long-term treatment of social anxiety disorder: the 12-to 24-week extension phase of a multicentre, randomized, placebo-controlled trial.

D.J. Stein; H.G.M. Westenberg; H. Yang; D. Li; L.M. Barbato

Fluvoxamine CR in the long-term treatment of social anxiety disorder: the 12-to 24-week extension phase of a multicentre, randomized, placebo-controlled trial.

Translated title of the contribution: Fluvoxamine CR in the long-term treatment of social anxiety disorder: the 12-to 24-week extension phase of a multicentre, randomized, placebo-controlled trial.

D.J. Stein
, H.G.M. Westenberg
, H. Yang
, D. Li
, L.M. Barbato

Psychiatry

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Fluvoxamine CR in the long-term treatment of social anxiety disorder: the 12-to 24-week extension phase of a multicentre, randomized, placebo-controlled trial.
Original language	Undefined/Unknown
Pages (from-to)	317-323
Number of pages	7
Journal	International Journal of Neuropsychopharmacology
Volume	6
Issue number	4
Publication status	Published - 2003

Cite this

@article{a15e2530e5164b0d822284fcaeac2474,

title = "Fluvoxamine CR in the long-term treatment of social anxiety disorder: the 12-to 24-week extension phase of a multicentre, randomized, placebo-controlled trial.",

author = "D.J. Stein and H.G.M. Westenberg and H. Yang and D. Li and L.M. Barbato",

year = "2003",

language = "Undefined/Unknown",

volume = "6",

pages = "317--323",

journal = "International Journal of Neuropsychopharmacology",

issn = "1461-1457",

publisher = "Oxford University Press",

number = "4",

}

Fluvoxamine CR in the long-term treatment of social anxiety disorder: the 12-to 24-week extension phase of a multicentre, randomized, placebo-controlled trial. / Stein, D.J.; Westenberg, H.G.M.; Yang, H. et al.
In: International Journal of Neuropsychopharmacology, Vol. 6, No. 4, 2003, p. 317-323.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Fluvoxamine CR in the long-term treatment of social anxiety disorder: the 12-to 24-week extension phase of a multicentre, randomized, placebo-controlled trial.

AU - Stein, D.J.

AU - Westenberg, H.G.M.

AU - Yang, H.

AU - Li, D.

AU - Barbato, L.M.

PY - 2003

Y1 - 2003

M3 - Article

SN - 1461-1457

VL - 6

SP - 317

EP - 323

JO - International Journal of Neuropsychopharmacology

JF - International Journal of Neuropsychopharmacology

IS - 4

ER -